blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2707030

EP2707030 - CANCER TREATMENTS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.12.2020
Database last updated on 09.09.2024
FormerThe patent has been granted
Status updated on  17.01.2020
FormerGrant of patent is intended
Status updated on  09.09.2019
FormerExamination is in progress
Status updated on  13.01.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): AL, MK
published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
200 First Street S.W.
Rochester, MN 55905 / US
[2020/08]
Former [2014/12]For all designated states
Mayo Foundation for Medical Education and Research
200 First Street SW
Rochester, MN 55905 / US
Inventor(s)01 / MARKOVIC, Svetomir N.
1320 Creek Lane SW
Rochester Minnesota 55902 / US
02 / NEVALA, Wendy K.
71 N. River Court N.E.
Rochester Minnesota 55906 / US
 [2014/12]
Representative(s)Gibson, Mark
Sagittarius IP
Marlow International
Parkway
Marlow SL7 1YL / GB
[2020/08]
Former [2014/12]Grund, Martin
Grund
Intellectual Property Group
Postfach 44 05 16
80754 München / DE
Application number, filing date12781802.909.05.2012
[2020/08]
WO2012US37137
Priority number, dateUS201161484151P09.05.2011         Original published format: US 201161484151 P
US201261609689P12.03.2012         Original published format: US 201261609689 P
[2014/12]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2012154861
Date:15.11.2012
Language:EN
[2012/46]
Type: A1 Application with search report 
No.:EP2707030
Date:19.03.2014
Language:EN
The application published by WIPO in one of the EPO official languages on 15.11.2012 takes the place of the publication of the European patent application.
[2014/12]
Type: B1 Patent specification 
No.:EP2707030
Date:19.02.2020
Language:EN
[2020/08]
Search report(s)International search report - published on:KR15.11.2012
(Supplementary) European search report - dispatched on:EP18.12.2014
ClassificationIPC:A61K39/395, A61K9/51, A61K47/68, A61K31/337, A61P35/00, A61K38/38, // C07K16/22, C07K16/28, C07K16/30
[2019/34]
CPC:
A61K39/39558 (EP,US); A61K31/282 (EP,US); A61K31/337 (EP,US);
A61K38/38 (EP,US); A61K39/3955 (EP,US); A61K47/643 (EP,US);
A61K47/6845 (EP,US); A61K47/6931 (EP,US); A61K9/0019 (EP,US);
A61K9/16 (US); A61K9/5169 (EP,US); A61P35/00 (EP);
C07K16/22 (EP,US); C07K16/2887 (EP,US); C07K16/30 (EP,US) (-)
C-Set:
A61K31/282, A61K2300/00 (EP);
A61K31/337, A61K2300/00 (EP);
A61K38/38, A61K2300/00 (EP);
A61K39/39558, A61K2300/00 (EP,US);
A61K39/3955, A61K2300/00 (EP)
(-)
Former IPC [2015/04]A61K39/395, A61K9/51, A61K47/48, A61K31/337, A61P35/00, // C07K16/22
Former IPC [2014/12]A61K39/395, A61K31/337, A61P35/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/12]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:KREBSBEHANDLUNGEN[2014/12]
English:CANCER TREATMENTS[2014/12]
French:TRAITEMENTS DU CANCER[2014/12]
Entry into regional phase09.12.2013National basic fee paid 
09.12.2013Search fee paid 
09.12.2013Designation fee(s) paid 
09.12.2013Examination fee paid 
Examination procedure09.12.2013Examination requested  [2014/12]
10.07.2015Amendment by applicant (claims and/or description)
07.06.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
12.01.2017Despatch of a communication from the examining division (Time limit: M04)
16.05.2017Reply to a communication from the examining division
31.08.2017Despatch of a communication from the examining division (Time limit: M04)
19.12.2017Reply to a communication from the examining division
20.04.2018Despatch of a communication from the examining division (Time limit: M04)
17.08.2018Reply to a communication from the examining division
20.12.2018Despatch of a communication from the examining division (Time limit: M02)
19.02.2019Reply to a communication from the examining division
10.09.2019Communication of intention to grant the patent
14.01.2020Fee for grant paid
14.01.2020Fee for publishing/printing paid
14.01.2020Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  12.01.2017
Opposition(s)20.11.2020No opposition filed within time limit [2021/04]
Request for further processing for:The application is deemed to be withdrawn due to failure to appoint a representative
19.07.2016Request for further processing filed
19.07.2016Full payment received (date of receipt of payment)
Request granted
29.07.2016Decision despatched
Fees paidRenewal fee
28.07.2014Renewal fee patent year 03
27.05.2015Renewal fee patent year 04
27.05.2016Renewal fee patent year 05
10.05.2017Renewal fee patent year 06
29.05.2018Renewal fee patent year 07
28.05.2019Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.05.201403   M06   Fee paid on   28.07.2014
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL19.02.2020
MC19.02.2020
MK19.02.2020
RS19.02.2020
SM19.02.2020
IS19.06.2020
[2022/31]
Former [2021/12]MC19.02.2020
RS19.02.2020
SM19.02.2020
IS19.06.2020
Former [2020/48]RS19.02.2020
SM19.02.2020
IS19.06.2020
Former [2020/40]RS19.02.2020
IS19.06.2020
Former [2020/37]RS19.02.2020
Documents cited:Search[Y]US2010112077  (DESAI NEIL P [US], et al);
by applicantUS2010112077
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.